This was shown to not only lead to CXCL13 driven myeloma growth but also to contribute to receptor activator of nuclear factor (NF) kΒ ligand (RANKL)-mediated osteoclastogenesis [85]. The gene discussed is CXCL13; the disease is plasma cell myeloma.